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an open research field with implications 
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Abstract 
Within the consolidated field of evolutionary development, there is emerging research on evolutionary aspects of central 
nervous system development and its implications for adult brain structure and function, including behaviour. The central 
nervous system is one of the most intriguing systems in complex metazoans, as it controls all body and mind functions. 
Its failure is responsible for a number of severe and largely incurable diseases, including neurological and neurodegen‑
erative ones. Moreover, the evolution of the nervous system is thought to be a critical step in the adaptive radiation of 
vertebrates. Brain formation is initiated early during development. Most embryological, genetic and evolutionary studies 
have focused on brain neurogenesis and regionalisation, including the formation and function of organising centres, and 
the comparison of homolog gene expression and function among model organisms from different taxa. The architec‑
ture of the vertebrate brain primordium also reveals the existence of connected internal cavities, the cephalic vesicles, 
which in fetuses and adults become the ventricular system of the brain. During embryonic and fetal development, brain 
cavities and ventricles are filled with a complex, protein‑rich fluid called cerebrospinal fluid (CSF). However, CSF has not 
been widely analysed from either an embryological or evolutionary perspective. Recently, it has been demonstrated in 
higher vertebrates that embryonic cerebrospinal fluid has key functions in delivering diffusible signals and nutrients to 
the developing brain, thus contributing to the proliferation, differentiation and survival of neural progenitor cells, and to 
the expansion and patterning of the brain. Moreover, it has been shown that the composition and homeostasis of CSF 
are tightly controlled in a time‑dependent manner from the closure of the anterior neuropore, just before the initiation 
of primary neurogenesis, up to the formation of functional choroid plexuses. In this review, we draw together existing 
literature about the formation, function and homeostatic regulation of embryonic cerebrospinal fluid, from the closure 
of the anterior neuropore to the formation of functional fetal choroid plexuses, from an evolutionary perspective. The 
relevance of these processes to the normal functions and diseases of adult brain will also be discussed.
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Background
From its embryonic beginnings and throughout 
adult life, the vertebrate brain is organised around an 
extraordinarily dynamic and complex fluid called cer-
ebrospinal fluid (CSF). The study of CSF attracts grow-
ing interest in brain development research, as it is an 
active signalling medium containing growth factors and 
signalling molecules involved in the regulation of multi-
ple cell functions in the central nervous system (CNS), 
including brain development, homeostasis and disease 
(for general reviews, see [1–7]). Today, several research 
findings have generated sufficient evidence to support 
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the hypothesis that embryonic CSF (eCSF) is involved in 
nearly all aspects of embryonic brain development.
Evo-devo (evolutionary development) has flourished in 
the last 20  years, since initial studies were published in 
the 1980s by Nobel Laureates Edward B. Lewis, Christi-
ane Nüsslein-Volhard and Eric Wieschaus. In these stud-
ies, some of the genes important in Drosophila fruit fly 
development, for example the Hox genes, were found to 
be broadly conserved among metazoans [8–10]. Even 
functions of these genes appeared to be conserved, 
as Hox vertebrate genes could substitute, at least par-
tially, for missing homolog Drosophila hox genes. More 
recently, variation in the nervous system of metazo-
ans has also begun to be examined from an evo-devo 
perspective. This has led to the emergence of the term 
evo-devo-neuro [11] or neuro-evo-devo [12]. A nearly 
ubiquitous theme in evo-devo studies on CNS is the 
search for cellular and/or molecular causes of evolution-
ary change in development trajectories. Just as the field 
of evo-devo has shed light on how diversity in animal 
body plans are variations on a few developmental themes 
[13, 14], so the study of neuro-evo-devo is beginning to 
illuminate how morphological and functional diversity 
in the brain are variations on developmental and neuro-
chemical themes [15, 16].
Most of molecular evo-devo research has focused 
on the functional comparison of homologous genes. 
In this respect, the genes that specify brain patterning 
early in development are highly conserved in bilaterians 
[17–20]. A comparative analysis of these genes in dif-
ferent taxa has provided insights into the early origin of 
the central nervous system and regional brain homolo-
gies in vertebrates and invertebrates. For example, all 
known bilaterian nervous systems are established via 
transforming growth factor β (TGF-β) family signalling, 
which arranges dorsoventral polarity, except in nema-
todes [17, 21, 22]. However, the chordate nervous system 
is dorsoventrally inverted compared with protostomes, 
and it has been suggested that hemichordates represent 
an intermediate body plan [23] (see Fig.  1 for a general 
cladistics phylogenetic tree). Similarly, anterior–poste-
rior patterning is in part defined by Otd/Otx (anterior) 
and Unpg/Gbx (posterior) expression, with Pax2/5/8 
expressed at the intersection [24–26]. Likewise, compar-
isons of patterning genes after the establishment of the 
anterior–posterior axis have identified evolutionary rela-
tionships among brain regions in bilaterians from very 
distant taxa. For example, expression of Pax6 and Emx1 
specify the pallial telencephalon, whereas Dlx and Nkx2.1 
specify subpallial regions [27, 28] (for a review, see [12]). 
Interestingly, invertebrate mushroom bodies have simi-
lar evolutionary origins to the pallium of vertebrates, as 
annelid mushroom bodies are also specified by Pax6 and 
Emx1 expression [29].
We will not continue with this line of argument as it 
is beyond the scope of this paper, except to cite another 
example of classic evo-devo research related to brain 
evolutionary development that has been analysed by the 
authors of this review and their collaborators to which 
we will return later. A comparison of the structure and 
expression of Evx genes in the cephalochordate amphi-
oxus (which belongs to the sister group of vertebrates) 
and its vertebrate homologs linked invertebrate and ver-
tebrate Evx functions across different taxa, and pointed 
to crucial evolutionary vertebrate innovations for brain 
development at the level of molecular and morphologi-
cal regionalisation [30]. Amphioxus has been reported 
to have two Evx genes that are genomically linked. 
AmphiEvxA is prototypical to the vertebrate Evx1 and 
Evx2 genes with respect to its sequence and expression, 
whilst AmphiEvxB is very divergent. Mapping the expres-
sion of AmphiEvxA onto a phylogeny showed a role in 
gastrulation, dorsal–ventral patterning, tailbud formation 
and neurogenesis. This suggests that basic Evx function 
has been retained throughout bilaterian evolution. Inter-
estingly for brain evolutionary development, AmphiEvxA 
is not expressed in amphioxus in the region homologous 
to the vertebrate midbrain–hindbrain boundary, a well-
known organising centre for brain development that is 
also called the isthmic organiser (IsO). This observation 
is consistent with the elaboration of the full organiser 
properties of this region being a vertebrate innovation. 
Later in this paper, we will go back to this organising 
centre, as its maintenance during early embryonic brain 
development also depends on the actions exerted by the 
eCSF [31].
To cite a final example, in this case also related to some 
aspects of animal behaviour, it has been reported that 
gonadotropin-releasing hormone, which is produced 
by the pituitary gland located at the base of the brain in 
vertebrates, is also produced in the most anterior part 
of the amphioxus body. This hormone is a key player in 
the control of vertebrate reproduction, and it has been 
shown to display seasonal variations in the Cephalo-
chordate amphioxus with respect to their reproduc-
tive cycle. This suggests that it plays an ancient role in 
the control of reproduction in all chordates, even before 
the evolution of a defined pituitary gland [32]. However, 
despite the explosion of evo-devo studies on some mor-
phological traits, the impact of behavioural factors upon 
speciation has scarcely been analysed [11], although it 
has been said that the elaborate and complex nervous 
system of amniotes is correlated with their behavioural 
repertoire [33].
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Similarly, very little work has been done on brain 
cephalic vesicles from the evo-devo perspective, and the 
same is true for both CSF in general and eCSF in particu-
lar. In this regard, from fetal stages through adult life, it 
has long been known that CSF is primarily produced by 
choroid plexuses. It has been shown that choroid plexus 
is derived from the same embryonic primordium as the 
hindbrain roof plate, and that it develops in a patterned, 
segmental manner, from lineage-restricted compart-
ments expressing Wnt1 [34]. Moreover, it has also been 
shown that molecular heterogeneity between telence-
phalic and hindbrain choroid plexi contributes to region-
specific, age-dependent protein secretion in vitro, which 
may contribute to dynamic signalling gradients across 
the mammalian cerebroventricular system [35]. How-
ever, eCSF has a role in vertebrate brain development at 
a much earlier stage, at least just after the closure of the 
anterior neuropore and before the initiation of brain pri-
mary neurogenesis, prior to the existence of a functional 
choroid plexus (for general reviews, see [1, 2, 4]).
The main objective of this review is to demonstrate 
that the evolutionary development of the embryonic 
brain cavity system, including the eCSF it contains and 
the mechanisms controlling its formation and homeo-
stasis, must also be taken into account to get a better 
overall understanding of brain development, CNS evolu-
tion, and neurological diseases. To present our thesis in 
an ordered way, we will first review data on evolutionary 
changes of the brain cavities in metazoans, primarily in 
the deuterostome lineage. We will then review research 
on eCSF function and composition, and on its forma-
tion and homeostasis regulation, much of which has been 
Fig. 1 Phylogeny and ontogeny of the CNS. a Phylogenetic relationships among main deuterostome clades, as cited in the text. b Ontogeny of the 
CNS, including the brain, in vertebrates. The origin of the different elements of the CSF system has been indicated. Similarities between deuter‑
ostome clades and CNS development in vertebrates have also been indicated. 1 Adult starfish possess a neural plate‑like nervous system similar 
to one from early vertebrate embryos, before the formation of the neural tube; 2 Adult Hemichordata possess a hollow dorsal nerve chord similar 
to one from vertebrate embryos before the closure of the anterior neuropore; 3 Urochordata and cephalochordata larvae possess a hollow dorsal 
nerve chord anteriorly open similar to one from vertebrate embryos before the closure of the anterior neuropore; 4 Urochordata and cephalochor‑
data adults possess a closed dorsal nerve chord similar to one from vertebrate embryos after the closure of the anterior neuropore; 5 In vertebrates, 
the neural tube becomes a physiologically sealed system from a very early developmental stage and the site of the embryonic transfer system is 
depicted
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developed by the authors and their collaborators over the 
last 10 years. Finally, we will integrate all these data in a 
comprehensive thesis about the actual importance of the 
developmental evolution of the brain cavities and eCSF, 
in the light of mammalian brain development and human 
diseases, with some comments on behavioural aspects.
Embryonic CSF evolutionary aspects: from the origin 
of deuterostomes to vertebrates
In vertebrates, brain formation begins early during devel-
opment. Generally speaking, its development involves 
several distinct phases (Fig. 1; for a general description of 
central CNS development, see [36–38]). First, a portion 
of the dorsal ectoderm develops into neural ectoderm 
and forms the neural plate, which is in contact with the 
amniotic fluid in amniotes (reptiles, birds and mammals) 
or with the surrounding water in the anamniotes (fish and 
amphibians). Second, the neural plate folds longitudinally 
to form the neural tube, which becomes the rudiment of 
the CNS, trapping some of the surrounding fluid within 
its lumen. The tube still remains in contact with the envi-
ronmental fluids through the open neuropores. Then, the 
neural tube polarises into a posterior spinal cord and an 
anterior expanded brain. Initially, the embryonic brain is 
a hollow fluid-filled vesicle surrounded by a pseudo-mon-
ostratified neuroepithelium. The subsequent closure of the 
anterior neuropore enables the organism to exert some 
control over CSF formation and composition for the first 
time. Thus, the CSF composition can become independent 
of environmental fluids. Finally, histogenesis of the neu-
roepithelium occurs. Interestingly, from the evo-devo per-
spective, this developmental process parallels evolutionary 
aspects of brain cavities and CSF formation and regulation 
in the deuterostome metazoan lineage (Fig. 1).
Metazoan phylogeny classifies the vertebrata as a sub-
phylum of the phylum Chordata, which also includes 
two other subphyla, the Urochordata and the Cepha-
lochordata. Within this scheme, the phylum Chordata 
is included in a major group, the Deuterostomia, which 
also includes the phyla Echinodermata and Hemichor-
data. These last two phyla are in turn grouped in the 
clade Ambulacraria. Chordates invariably possess a 
notochord and a dorsal neural tube, and share tadpole-
type larvae containing the notochord and a hollow nerve 
cord. However, Ambulacrarians have dipleurula-type 
larvae containing a hydrocoel. It has been proposed that 
the evolutionary occurrence of tadpole-type larvae with 
a hollow nerve chord was fundamental to the origin of 
chordates [39]. The sister group of Deuterostomia are the 
Protostomia, including the clades Priapulida, Nematoda, 
Arthopoda, Platyhelminthes, Mollusca and Annelida, 
none of which exhibit a hollow nerve tube with an inter-
nal lumen or brain cavities.
It is thought that the CSF system evolved in the deu-
terostome lineage from the ancestor of Ambulacraria and 
Chordata, as a way to maintain the chemical environ-
ment required for the functioning of CNS cells, includ-
ing the neuroendocrine pathways [40]. In this context, it 
has been said that the system of CSF-contacting neurons 
has a special role in taking up, transforming and emit-
ting nonsynaptic signals mediated by this brain fluid. 
Most CSF-contacting neurons send dendritic processes 
into the CSF of the brain ventricles or central canal, 
where they form terminals bearing stereocilia. The axons 
of these CSF-contacting neurons transmit information 
taken up by dendrites and perikarya to synaptic zones 
of various brain areas. The importance of nonsynaptic 
signal transmission in the function of nervous tissue has 
been confirmed, and it has been considered that its evo-
lutionary origin could be the deuterostome ancestors, 
before the split between Ambulacraria and Chordata 
clades (reviewed by [41]).
Echinoderms, such as starfish, have a neural plate-
like nervous system. The neurons of the radial nerves 
and “brain” are always in contact with seawater, which 
allows them to directly detect its chemical composition 
and other physical parameters such as water tempera-
ture, and modulate the activity of the nervous system and 
overall animal behaviour accordingly (Fig. 1) [40, 42–44]. 
However, the open nature of this neural plate-like nerv-
ous system means that it cannot respond to neuroendo-
crine or other molecular signalling pathways. In contrast, 
Hemichordata, such as the acorn worm Saccoglossus kow-
alevskii, which may represent an intermediate body plan 
[23], exhibit both dorsal and ventral nerve cords. While 
the ventral cord runs only as far as the collar, the dorsal 
cord reaches into the proboscis, and is often hollow.
Regarding the phylum Chordata, the development of 
the cephalochordate amphioxus Branchiostoma lanceo-
latum, includes a larval stage in which the neural plate 
is folded longitudinally to form a neural tube, but the 
anterior neuropore remains open throughout this stage. 
This allows seawater to enter the ventricular lumen of the 
lancelet larval “brain”. Thus seawater represents the first 
“internal” fluid environment of lancelet brain which con-
sequently depends directly—but not necessarily exclu-
sively—on the external environment [40, 41]. In these 
organisms, nearly all neurons are found to be in direct 
contact with the internal fluid of the neural tube-like 
central nervous system. However, when lancelets reach 
adulthood, the anterior neuropore closes and the ven-
tricular lumen of the “brain” becomes a closed system 
(Fig.  1). Thus, the composition of this fluid no longer 
depends directly on the surrounding water environment, 
but largely on the activity and metabolism of the organ-
ism. This modified sea water constitutes the primary CSF. 
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At this stage, the regulatory function of CSF-contacting 
neurons likely become important through their interac-
tion with the metabolic state of the brain tissue [44–46].
Similarly, the development of the Urochordate ascidia 
Ciona intestinalis, includes a larval stage in which the 
neural plate is folded longitudinally to form a neural tube, 
but the anterior neuropore also remains open (Fig.  1). 
Unlike lancelet larval development, ascidians follow an 
invariant pattern of embryonic cleavage, and their larval 
CNS possess fewer than 400 cells, most of which are in 
direct contact with the internal fluid of the neural tube-
like central nervous system, as revealed by cell lineage 
studies [47–49]. Nevertheless, as in Cephalochordates, 
when ascidians reach adulthood the anterior neuropore 
closes and the ventricular lumen of the “brain” becomes 
a closed system, which includes a sensory vesicle (Fig. 1).
In lancelets and ascidians, nearly all neurons contact 
the lumen of the central nervous system. Consequently, 
it has been suggested that the CSF-contacting neurons 
of vertebrates are derived from an ancient epithelial 
neuron-type of the ectoderm, and thereby represent a 
phylogenetically old cell type, the “protoneuron” [50]. In 
mammals, only the CSF-contacting neurons of the spinal 
cord retain their ancient structure; the rest of the neu-
rons no longer contact CSF [41].
Finally, in vertebrates, the anterior neuropore closes 
very early in neural tube development, just before pri-
mary neurogenesis starts, and thus the composition of 
the CSF contained within the cephalic cavities depends 
exclusively on the surrounding tissue and on the rest of 
the embryo from this stage. Environmental conditions 
are no longer directly detected by CNS neurons, and 
this function is passed to specific sensory organs. This 
opens up the possibility of precisely regulating CSF com-
position and homeostasis. The gain in CSF regulation 
implies, or has been paralleled by, a gain in morphologi-
cal and physiological neural complexity. Thus, it has been 
reported that, at least in mammals, CSF is essential for 
the formation of the layers of neurons [51, 52] in the evo-
lutionary progressively enlarged cerebral cortex, includ-
ing the highly developed neocortex [53], a brain region 
that is absent in fish and amphibians (anamniotes).
CSF composition and homeostasis in vertebrate fetal 
and adult brains are tightly regulated by the choroid 
plexus, whose epithelial cells establish a blood-CSF bar-
rier [54, 55] (reviewed by [56]). The choroid plexus is a 
vascular structure in the brain ventricles that secretes 
CSF by promoting the transport of certain molecules and 
electrolytes from blood plasma and producing others that 
are delivered directly to the ventricles [57–61]. All verte-
brates analysed, from fish to mammals, possess a set of 
choroid plexuses [40, 56] and it has been described that 
the choroid plexus increases in complexity among the 
various vertebrate classes. However, no choroid plexus 
has been detected in non-vertebrate chordates, such as 
Cephalochordates. Acting in parallel, CNS homeostasis 
in adult vertebrates is also controlled by the blood–brain 
barrier (BBB) vessels in the brain, which significantly 
impede entry from the blood to the brain of virtually all 
molecules, except those that are small and lipophilic. 
However, BBB vessels also allow sets of small and large 
hydrophilic molecules, e.g., gene products, to enter the 
brain via various transport processes (reviewed by [62]). 
Control of eCSF production and homeostasis in verte-
brate embryos from the closure of the anterior neuropore 
to the formation of functional choroid plexuses during 
fetal stages has not been analysed until recently. This 
developmental stage is particularly interesting for brain 
formation, since it is mainly characterised by rapid brain 
anlagen growth and initiation of primary neurogenesis in 
the neural progenitor cells lining the cavities.
Embryonic CSF function: from neural progenitor cell 
functions to the establishment of organising centres
CSF has intrigued philosophers, physicians and scientists 
for a long time. The earliest mention of a fluid within the 
brain dates back to ancient Egypt [5], and the first stud-
ies of barriers in the brain are attributed to Herophilus 
(335-280 BCE), who described the choroid plexus. The 
first reports on CSF functions are attributed to Galen 
of Pergamon (129-200/216). Studies on eCSF are much 
more recent, dating back to the mid-twentieth century. 
Due to its specific molecules and mechanical properties, 
it has been determined that eCSF plays several crucial 
roles during the early stages of brain development and 
may influence adult brain function.
Using several experimental approaches, mainly in 
zebrafish, chick and mouse embryos, it has been reported 
that the progressive increase in eCSF volume exerts posi-
tive pressure against the neuroepithelial walls and gen-
erates an expansive force, which contributes to brain 
expansion [63–65]. Moreover, as proteoglycans are the 
major components of the extracellular matrix found 
in embryo brain cavities, it has been suggested that the 
special osmotic properties of chondroitin sulfate proteo-
glycan and other proteoglycans in eCSF may cause water 
retention in the cavities [66, 67]. This would contribute 
to the generation and regulation of inner cephalic hydro-
static pressure.
Studies on in vitro cultures of neuroectodermal explants 
from chick and rat embryos at E4 and E12.5 (E stands for 
embryonic development day) respectively, which corre-
spond to the stage at which the anterior neuropore has 
just closed and brain primary neurogenesis is initiated, 
have shown that diffusible molecules contained within 
eCSF, including growth factors and cytokines, contribute 
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to the regulation of some basic neural progenitor cell 
functions, i.e., their survival, proliferation, and differen-
tiation [68–70]. Furthermore, it has been reported that 
neuroectodermal tissue explants cultured with only a 
chemically defined medium show lower numbers of pro-
liferating cells, an increased number of apoptotic cells, 
and a severe decrease in the number of cells engaged in 
the process of neural differentiation compared to control 
embryos. However, when the medium is supplemented 
with eCSF, these basic cellular parameters remain close to 
those of embryos developed in ovo (for chicks) or in utero 
(for rats). It has also been reported that repeatedly drain-
ing eCSF from embryonic zebrafish brain vesicles not only 
prevents brain enlargement due to the lack of hydrostatic 
pressure (see paragraph above), but also decreases the 
rate of cell survival [63], paralleling the effects reported in 
amniotes (at least in birds and mammals). Moreover, the 
particular effect of the eCSF on neural progenitor cells 
depends on the developmental stages from which both 
the fluid and the cells have been obtained. This suggests 
that the composition of the eCSF varies with time, as 
does the receptiveness of the cells, most probably through 
developmentally regulated specific receptors [52, 71, 72].
Most of the proteins identified in the eCSF (see the 
section below on eCSF protein content) have known 
physiological functions during embryonic development 
in systems other than CSF that nevertheless are con-
sistent with the overall roles reported for eCSF during 
CNS development [73, 74]. Thus, functional in vivo and 
in vitro analysis of some of these molecules at the begin-
ning of primary neurogenesis, before the formation of 
functional choroid plexuses, has revealed specific roles 
in the function of eCSF in neuroepithelial progenitor cell 
behaviour. For example, it has been reported that immu-
noblocking of active FGF2 in eCSF in chick embryos 
severely disrupts neuroepithelial stem cell proliferation 
and differentiation [75]. Similarly, it has been reported 
that the LDL lipid fraction, transported by apolipopro-
tein B in eCSF, is also involved in regulating neuroepithe-
lial progenitor cell proliferation and differentiation in the 
same system [76].
Other reports in chick embryos have shown that reti-
nol-binding protein (RBP) is responsible for transport-
ing all-trans-retinol from the embryonic plasma to the 
eCSF (as detected by high-performance liquid chroma-
tography), from where it reaches the neuroepithelium 
to be transformed into retinoic acid by the retinoic acid-
synthesising enzymes expressed in this embryonic tissue; 
and that the presence of these molecules is necessary 
both in vivo and in vitro to maintain basic neuroepithelial 
cell parameters (i.e., proliferation and differentiation [77, 
78]). Interestingly, a parallel situation has been described 
recently in zebrafish embryos [79]. This suggests that at 
least some of the basic mechanisms in which eCSF is 
involved during early brain development are conserved 
among vertebrates. It has also been shown that large 
glycoprotein SCO-spondin contributes to the control 
of neuroepithelial cell proliferation via eCSF in chick 
embryos [80], and that eCSF contained in nanovesicles 
carrying evolutionarily-conserved molecules promotes 
neural stem cell proliferation [81]. Other findings include 
the capacity of eCSF to activate neurogenesis of neural 
precursors within the subventricular zone of the adult 
mouse brain [82].
Therefore, eCSF contains specific molecules that affect 
neural progenitor cell behaviour. In addition, eCSF has 
been reported to be involved in regulating the expression 
of genes that are known to be implicated in brain pat-
terning [31]. Thus, when dorsal mesencephalic neuroepi-
thelial explants lacking IsO (a known organising centre 
for mesencephalon and brain development) or explants 
including IsO are cultured in a chemically defined 
medium but in the absence of eCSF, the typical expres-
sion of dorsal mesencephalic and IsO genes, i.e., Otx2 
and Fgf8 respectively, is disrupted. Conversely, when dor-
sal mesencephalic explants including IsO are cultured in 
an eCSF-supplemented medium, they do express these 
genes. Interestingly, when dorsal mesencephalic explants 
lacking IsO are cultured with an eCSF-supplemented 
medium, they also show ectopic expression domains of 
Shh in the mesencephalic neuroectoderm, even though 
this gene is typically expressed in the ventral, but not the 
dorsal, neuroectoderm. Only the concurrence of eCSF 
and IsO allow this tissue to mimic its typical pattern of 
gene expression, which suggests that IsO and some mole-
cules in eCSF act synergistically in brain development, as 
is the case for the retinoic acid system [77, 78]. It is worth 
noting that the elaboration of the full organiser proper-
ties of this region [30] and embryonic control over eCSF 
composition are both vertebrate innovations that act syn-
ergistically in brain development [31].
Moreover, the presence of folate and some of its deriva-
tives within fetal CSF has been reported [83], as well as 
the presence of reduced-folate carriers within the neu-
roepithelium from E9.0 in mouse embryos [84, 85]. 
Folate is known to prevent neural tube defects when 
supplemented prior to conception, and it has also been 
reported to contribute to the establishment of epigenetic 
modifications [86–88], which in turn are crucial for CNS 
development [89], including adult behaviour [90–93]. 
Taken together, the results of all the studies mentioned 
in this section point to the crucial role of this embry-
onic fluid in the regulation of basic neural progenitor cell 
function and CNS development, before the formation of 
a functional choroid plexus. This may have implications 
for adult brain function.
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Embryonic CSF protein content: from extracellular matrix 
components to growth factors
Classic studies performed on several species (chick 
embryos at developmental stages E2.5 to E6.5; sheep 
fetuses at E35 and E60; and rats from E12 to E22 and neo-
natal) showed that eCSF has a higher concentration of 
total proteins than adult CSF [94–100]; reviewed by [101]. 
Initially, individual proteins were identified based on 
crossed immunoelectrophoresis or by SDS-PAGE protein 
separation and molecular mass inference. More recent 
and accurate proteomic analyses of avian and mamma-
lian eCSF have confirmed and greatly expanded most of 
the initial findings. The first reports to use conventional 
proteomic techniques (2D-electrophoresis, in-gel diges-
tion, and ESI–MS/MS mass spectrometry analysis) 
were carried out on chick and rat eCSF at E4 and E12.5, 
respectively, which corresponds to the developmental 
stages when there is maximum neuroepithelial progeni-
tor cell proliferation, and coincides with the beginning 
of brain neural differentiation. These studies showed the 
presence of dozens of specific proteins within this fluid, 
most of which may be involved in brain development, by 
inference from their roles in systems other than CSF [73, 
74]. They include gene products involved in extracellular 
matrix, osmotic pressure and ion carriers, cell death and 
quiescence, apolipoproteins, retinol and vitamin D carri-
ers, and antioxidant and antimicrobial products, among 
others (for a comparative review, see [101]).
From the evolutionary point of view, the most remark-
able dissimilarity between chick and rat eCSF proteomes 
is the presence of enzymes and enzyme regulators in rat 
eCSF, as well as an increased number of members of the 
apolipoprotein family. Only two different apolipoproteins 
have been identified in chicks, AI and AIV, whereas at 
least five have been found in rats, including AI and AIV, 
as well as B, E, and M. These differences may be related to 
the higher complexity of the CNS in mammals, although 
apolipoprotein B was later identified in chick eCSF by 
Western-blot analysis using specific antibodies [76]. 
These dissimilarities may also be due to differences in 
the timing of choroid plexus formation between the two 
species. In this regard, E4.5 chick embryos correspond 
to a developmental stage that is 2.5 days before the first 
appearance of the choroid plexus. However, in E12.5 rat 
embryos, transthyretin-positive choroid plexus primor-
dium starts to be detected, although it is probably not 
fully functional, as suggested by the coexistence of a spe-
cific, temporary embryonic blood-eCSF barrier [102] (see 
the section below on eCSF composition and regulation).
An extensive and thorough proteome analysis of rat 
and human eCSF from several different stages and loca-
tions of brain vesicles [i.e., E12.5, E14.5 from both the 
lateral and fourth ventricles, and E17.5 during cortical 
development in rats; and Carnegie Stage 20 (CG20) in 
humans] has also been reported [103]. They identified 
423, 318, 249, and 382 proteins, respectively, in rats, and 
188 proteins in humans, 130 of which are shared with 
rats. Although differences in protein number between 
rat and human eCSF has not been fully explained, it has 
been suggested it may be due to the difficulty in experi-
mentally matching stages of embryonic cortical develop-
ment between humans and rats [103], as the composition 
of this fluid has been proved to be highly dynamic. The 
categorisation of these proteins based on their molecu-
lar function and action on biological processes are almost 
identical, which suggest that they represent essential 
eCSF functions. They include several growth factors and 
cytokines. Similar results were obtained more recently 
by Bueno, Miyan and Parvas on eCSF from chick and rat 
embryos at E4 and E13 respectively, using a high-perfor-
mance liquid chromatography ion-trap column coupled 
to an ESI MS/MS mass spectrometer, which is a more 
sensitive technique (unpublished results).
Other studies have examined the presence of growth 
factors and cytokines within eCSF by immunohisto-
chemical procedures, since these molecules, crucial for 
controlling developmental processes, exert their actions 
at very low concentrations, and thus are not usually 
detected by conventional proteomic techniques. For 
example, Western-blot analyses of both avian and mam-
malian eCSF using specific antibodies have revealed the 
presence of fibroblast growth factor 2 (Fgf2) [75], epider-
mal growth factor (Egf) [104], and leukemia inhibitory 
factor [105], which are known to be involved in the reg-
ulation of a number of developmental processes. Taken 
together, these studies, whose overall results are relatively 
similar, have proved to be complementary. They reinforce 
the putative capacity of eCSF to influence the behaviour 
of neuroepithelial cells and CNS development through its 
constituent molecules, including behavioural aspects of 
adult brain function.
It has been reported that a number of neurological 
and neurodegenerative diseases, including dementia and 
schizophrenia, involve alterations in CSF protein content, 
which in some cases is also being used in diagnostics 
(see, for example, [101, 106–110]). It is tempting to spec-
ulate that abnormal eCSF composition early during CNS 
development may favour the appearance of these diseases 
during adulthood, due to interference with developmen-
tal mechanisms.
Regulation of embryonic CSF composition: the importance 
of the blood‑eCSF barrier for controlling eCSF homeostasis 
in early brain development
As discussed in previous sections, the evolutionary 
development of brain cavities in vertebrates has provided 
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the opportunity to tightly control eCSF composition and 
homeostasis from very early brain development stages. 
This in turn may allow this fluid to act as a mechanism 
for establishing neuroendocrine pathways and enabling 
a progressive increase in brain complexity. As described 
above, this hypothesis is supported by the particular 
effect of the specific molecules on neuroepithelial pro-
genitor cell behaviour and on the establishment of organ-
ising centres, which are crucial for CNS development 
and functionality. The hypothesis is also supported by 
the molecular content of eCSF, as revealed by proteomic 
analyses and other technical approaches. However, to 
achieve this, barrier systems are required to control eCSF 
formation, composition and homeostasis from early 
brain developmental stages.
In fetuses and adults, there are several barrier systems 
that control the internal environment of the brain, such 
as the blood–brain barrier between the lumen of cerebral 
blood vessels and the brain parenchyma, the blood-CSF 
barrier between choroid plexus blood vessels and adult 
and fetal CSF, and the outer CSF-brain barrier between 
the subarachnoid space and overlying structures. The 
integrity of these barriers is crucial, as both the stabil-
ity and specificity of this fluid environment are essential 
for normal brain development and function [111]. The 
barriers significantly impede the passage of virtually all 
molecules from the blood to the CSF, except for small, 
lipophilic ones, and some sets of both small and large 
hydrophilic molecules, such as proteins, that can enter 
the CSF by specific transport processes.
In avian and mammalian embryos, an inner CSF-brain 
barrier between the eCSF and the brain parenchyma has 
been reported that impedes the passage of virtually all 
molecules [102, 112]. However, the fact that eCSF con-
tent has proven crucial for these stages of CNS develop-
ment implies the need for a physiological blood-eCSF 
transfer system that controls the initial composition 
and homeostasis of eCSF, before the formation of func-
tional fetal choroid plexuses. This need is reinforced 
by the fact that most of the abundant protein fractions 
contained within the eCSF are produced outside of the 
brain anlagen, and thus they have to be transferred from 
the embryonic serum to the eCSF by crossing an inner 
eCSF-brain barrier [112]. In this context, the existence 
of an inner eCSF-brain barrier has been demonstrated 
by the microinjection of a small-sized 3 kDa tracer, bio-
tin dextran amine(BDA3000), into the cephalic cavity, or 
conversely into the outflow of the heart of embryos at dif-
ferent embryonic days during chick development [102]. 
It has been shown that this inert tracer cannot cross the 
inner and temporary eCSF-brain barrier transfer area 
from day E4 on, i.e., after the closure of the anterior neu-
ropore coinciding with the initiation of brain primary 
neurogenesis. However there exists a small subset of 
endothelial cells and adjacent neuroepithelial cells that 
remove the tracer from the brain cavities into the circu-
lation. This subset of cells, which is located in the ven-
tral mesencephalon and in the most anterior part of the 
ventral prosencephalon, lateral to the floor plate, may act 
as a temporary functional barrier transfer system, to con-
trol eCSF composition and homeostasis [102]. A number 
of studies published during the last 6  years, conducted 
primarily on chick embryos from E3 to E5 and on rat 
embryos at an equivalent developmental stage from E12.7 
to E13.7, have demonstrated the existence of this func-
tional, dynamic barrier transfer system. It is formed by 
endothelial cells of specific blood vessels and by colum-
nar cells of the differentiating neuroepithelium. The sys-
tem is active from closure of the anterior neuropore, at 
the beginning of brain primary neurogenesis and before 
the choroid plexus becomes functionally active. It con-
tributes to the brain’s internal milieu at this crucial stage 
of development (see [1, 2] for a review; see Table 1 for a 
chronology including main aspects of embryonic blood–
brain barrier transfer system in chick and rat).
It has been reported that from chick E3, eCSF has a 
complex protein composition that differs from that of 
blood plasma, and that the relative concentration of these 
proteins varies during development and with respect to 
adult CSF [95–97, 99, 100]. Initially, eCSF is derived from 
trapped amniotic fluid. However, after the closure of the 
anterior neuropore, the brain cavities become physiologi-
cally sealed enabling the tight regulation of eCSF com-
position. Furthermore, it has been demonstrated in mice 
that amniotic fluid and eCSF proteomes begin to diverge 
during development after the closure of the anterior neu-
ropore, and that these changes in protein composition 
allow neural progenitor cell self-renewal [113]. This sug-
gests that the composition of eCSF is somehow regulated 
from this initial stage of brain development to fulfil spe-
cific functions on neuroepithelial progenitor cells. Vari-
ous experiments have demonstrated that the transport 
Table 1 Chronology of the embryonic blood–brain barrier 
transport system formation




Closure of anterior neuropore/initial 
differentiation of eCSF protein 
content
E1.7−E2 E10.5−E11
Brain cavity becomes physiologically 
sealed
E3.5−E4 E12.4−E12.7
Transient embryonic blood–brain 
barrier starts to be physiologically 
functional
A bit before E4 A bit before E12.7
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of proteins from the blood plasma to the eCSF and vice 
versa in chick embryos at E4 and E5 is tightly regulated, 
as is the homeostatic control, which is crucial for eCSF 
function in brain development [102, 114]. These experi-
ments included the quantification of endogenous chick 
proteins present in both the blood plasma and the eCSF 
(ovalbumin, retinol-binding protein, fibroblast growth 
factor No. 2, and immunoglobulin IgY), as well as the 
microinjection of several proteins of different molecular 
size into the brain cavities or alternatively into the out-
flow of the heart of chick embryos at E4 to examine the 
properties of this blood-eCSF barrier transfer system. 
The proteins used in the microinjection experiments 
included both endogenous chick proteins that are nor-
mally present in the eCSF or conversely not normally 
detected within this fluid, and proteins from sources 
other than chicks (bovine serum albumin, myosin heavy 
chain from rabbit, fibroblast growth factor No. 2, plasma 
retinol-binding protein, a recombinant protein from glu-
tathione-S transferase from Schistosoma japonicum, alco-
hol dehydrogenase from Drosophila lebanonensis, and 
ovalbumin). These experiments demonstrated that the 
physiological ratio of chick endogenous proteins between 
the eCSF and the blood plasma is regulated developmen-
tally, as the transfer rates varied from E3 to E5 according 
to their activity in brain development. It was also shown 
that the transfer of both chick endogenous proteins and 
microinjected proteins across the blood-eCSF interface 
was highly protein-specific. In other words, proteins that 
are not normally present within eCSF are never trans-
ferred from the blood serum to the brain cavity when 
microinjected into the outflow of the heart, and they are 
also rapidly removed from the eCSF when microinjected 
into the brain cavities. Interestingly, the ratio of trans-
fer for these proteins was tightly regulated and never 
exceeded the physiological ratios for any developmental 
stage, even when the proteins were injected at levels 10- 
to 100-fold higher than normal physiological conditions 
[102].
A histological analysis of protein transfer across the 
blood-eCSF barrier transfer system demonstrated that it 
occurs only in a specific embryonic region, located in the 
brain stem lateral to the floor plate, in the ventral mesen-
cephalon and the most anterior part of the ventral pros-
encephalon [102] (Fig. 1). This location does not coincide 
with the area where the fetal choroid plexus will start to 
develop, i.e., from an invagination of the dorsal roof plate 
along the midline of the neural tube. Therefore, this tran-
sient embryonic blood-eCSF barrier function appears 
to be independent of the choroid plexus, and probably 
fulfils a function that is temporarily lacking after the 
formation of a physiologically-sealed brain. Immunohis-
tological analysis has also revealed that protein transport 
across this transient blood-eCSF barrier uses transcellu-
lar routes by means of caveolae [115]. It has also revealed 
the existence, in the same neuroepithelial and endothe-
lial cells, of water and ion channels (i.e., Aqp1, Aqp4, and 
Kir4.1 [116]) and glucose transporter (Glut 1) in both 
chick and rat embryos at an equivalent developmental 
stage [115].
Concluding remarks
Many of the world’s first human civilisations developed 
along riverbanks and seashores, as they used the nearby 
fluid medium as a food resource. As civilisations devel-
oped over time and gained social and technological com-
plexity, they also used the fluid pathways provided by 
rivers, lakes, seas and oceans to promote transport and 
cohesion between near and far territories. These activi-
ties included the trading of goods and news by postal 
services, to which people responded by adapting both 
their individual and collective behaviour to the chang-
ing environment. Over time, civilisations modified these 
fluid pathways to better serve their needs, for example 
by constructing harbours, dams and canals to regulate 
water influx, and docking for transport and irrigation. 
These cultural and technological human modifications 
of the fluid environment in some ways parallel and serve 
as an analogy of the evolutionary developmental changes 
that occur in CNS with regard to the existence of inter-
nal brain cavities filled with CSF, and with respect to CSF 
and eCSF composition and homeostasis regulation, as 
reviewed in this paper.
Thus, as human civilisations gain social complexity 
through the progressive use and control of fluid medi-
ums, so does the CNS of deuterostomes with respect 
to the variety and complexity of neural cells and brain 
regionalisation. The vertebrate brain is organised, from 
its embryonic origins and throughout adult life, around 
this extraordinarily dynamic and complex fluid. CSF 
composition and homeostasis is tightly regulated from 
the closure of the anterior neuropore, just before brain 
primary neurogenesis starts. In contrast, in other deu-
terostomes, such as cephalochordates and Urochordates, 
CSF regulation starts during adulthood or is never pre-
sent (as in Ambulacrarians). Hence, the evolutionary 
development of brain cavity systems, CSF, and CSF com-
position and regulation are milestones in vertebrate (and 
human) brain evolutionary development. They need to 
be further analysed to fully understand brain function, 
and may have implications for the increase in behavioural 
repertoire.
It will be interesting to investigate, in the light of evolu-
tion, whether the blood-eCSF embryonic barrier transfer 
system initially developed when brain cavities become 
sealed in early brain developmental stages, and thus is 
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specific to the vertebrate lineage. Alternatively, it may 
represent the initial chordate evolutionary condition and 
may also be present in adult cephalochordates and uro-
chordates, which have a closed cephalic cavity, but no 
choroid plexuses. If the latter is the case, the blood-eCSF 
embryonic barrier transfer system has been heterochro-
nically reused in vertebrate embryos before the newly 
developed and far more complex choroid plexus is fully 
active.
Conclusions
Controlling CSF composition and homeostasis is a mile-
stone in the development and evolution of the CNS in 
deuterostome metazoans, especially in chordates and 
vertebrates. In higher vertebrates, eCSF formation is 
tightly regulated by a transient blood–brain barrier trans-
fer system located ventrally in the cephalic cavities from 
very early stages of brain development, just after the clo-
sure of the anterior neuropore, before choroid plexus 
becomes physiologically functional. It is known that gene 
products and other molecules contained within this fluid 
exert crucial functions on neuroepithelial progenitor 
cell survival, proliferation, differentiation and pattern-
ing. The evolutionary development of these barriers and 
transfer systems has contributed to the increase in brain 
complexity. Thus, further and deeper examination of the 
mechanisms regulating CSF composition and homeosta-
sis as well as the functions it exerts on neuroepithelial 
progenitor cells in model organisms from different deu-
terostome taxa may provide new and important data for 
the evolutionary and developmental comprehension of 
the vertebrate brain.
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